WAM
COCH icon

Wolverine Asset Management’s Envoy Medical COCH Stock Holding History

Wolverine Asset Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,678
Closed -$16.9K – 1829
2023
Q1 		$16.9K Sell
1,678
-189,167
-99% -$1.9M ﹤0.01% 1366
2022
Q4 		$1.91M Sell
190,845
-27,730
-13% -$276K 0.02% 582
2022
Q3 		$2.15M Buy
218,575
+202,810
+1,286% +$1.99M 0.02% 546
2022
Q2 		$154K Buy
+15,765
New +$154K ﹤0.01% 1267
2021
Q4 		– Sell
-891
Closed -$8K – 2077
2021
Q3 		$8K Buy
+891
New +$8.63K ﹤0.01% 1793

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Wolverine Asset Management's COCH Position: Q2 2023 in Review

Wolverine Asset Management sold out of Envoy Medical (COCH) in Q2 2023, closing a stake of 1,678 shares — an estimated $16.9K sold.

Wolverine Asset Management first reported a position in COCH in Q3 2021 and held it in 5 quarters. The position peaked at $2.15M in Q3 2022. 21 funds tracked by Wall St. Rank hold COCH as of Q2 2023.

  • Wolverine Asset Management reported no remaining Envoy Medical position as of Q2 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 1,678 Envoy Medical shares in Q2 2023, an estimated $16.9K.
  • Wolverine Asset Management first reported a position in Envoy Medical in Q3 2021 and held it in 5 quarters.
  • Wolverine Asset Management's Envoy Medical position peaked at $2.15M in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.